Don’t let the cost of fibroid treatment force you toward surgery you may not need. We
help eligible patients access Oriahnn for as little as $69.95 per month through manufacturer Patient Assistance Programs.
The Oriahnn Prescription Assistance Program is a manufacturer-sponsored initiative that provides Oriahnn at no medication cost to qualifying patients who cannot afford it. The program provides up to 12 months of medication at no cost if approved, and patients can reapply as needed. Patients with insurance or Medicare Part D may also be eligible as exceptions on a case-by-case basis.
Uterine fibroids affect up to 80% of women by age 50, and for millions, the heavy menstrual bleeding they cause is devastating — soaking through pads or tampons every hour, passing large clots, and living with chronic iron-deficiency anemia. For decades, the primary treatment options were surgical. Oriahnn changed that equation by offering an oral medication that can significantly reduce heavy bleeding without surgery — but at over $1,100/month with no generic alternative.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment.
Medicare Part D patients accepted. If you have Medicare Part D coverage, you may still qualify for the Patient Assistance Program through case-by-case exceptions.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$1,200.00 | Save ~$1130.05/mo |
| CVS Pharmacy | ~$1,277.00 | Save ~$1207.05/mo |
| Walmart | ~$1,180.00 | Save ~$1110.05/mo |
| Costco | ~$1,160.00 | Save ~$1090.05/mo |
| Kroger | ~$1,118.00 | Save ~$1048.05/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Patient Assistance Program is free to apply for and provides medication at no cost if approved. But the process involves detailed applications, prescriber coordination, documentation, and ongoing management. Our $69.95/month covers full advocacy: applications, doctor coordination, documentation, refill management, and re-enrollment — so you focus on your health, not paperwork.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through Afford My Prescriptions is the better long-term solution:
Eligibility is generally determined by annual household income levels. Most programs follow guidelines that include a limit of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because these requirements can vary, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for assistance.
Oriahnn (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules) is a twice-daily prescription medication used to control heavy menstrual bleeding caused by uterine fibroids in premenopausal women. It is the first FDA-approved oral medication specifically designed for this condition, combining three active ingredients in a unique two-capsule daily regimen: a morning capsule containing elagolix with hormonal add-back therapy (estradiol and norethindrone acetate), and an evening capsule containing elagolix alone. Treatment is limited to a maximum of 24 months.
How It Works:
Oriahnn manages heavy bleeding by targeting the hormonal signals that feed uterine fibroids. Its active ingredient, elagolix, blocks GnRH receptors in the brain to lower the production of estrogen and progesterone. To prevent side effects like bone loss and hot flashes, the medication includes “add-back” therapy with small doses of estradiol and norethindrone. This balance reduces bleeding while replacing just enough estrogen to protect bone health and minimize menopausal symptoms.
Form and Use:
The treatment involves a specific twice-daily dosing regimen that should be taken with food. Patients take one combined capsule containing elagolix and add-back hormones in the morning, followed by an elagolix-only capsule in the evening. Because estrogen suppression can impact bone density over time, the maximum duration for this treatment is limited to 24 months. Consistency is key to maintaining the hormonal balance required to control symptoms.
Generic Availability:
As of April 2026, there is no generic version of Oriahnn commercially available in the United States. This specific combination and dosing regimen remains under patent protection, making it a brand-only medication. While Myfembree is a competing brand-name medication that treats similar conditions with once-daily dosing, it is also a brand-only product within a similar price range.
Warnings:
Oriahnn must not be used during pregnancy, and patients should disclose any history of liver problems, blood clots, or cardiovascular disease to their doctor. Because long-term use can affect bone density, a baseline bone density scan and periodic monitoring may be recommended. It is important to discuss all health history with a provider to ensure the treatment is safe for your specific medical profile.
Oriahnn costs approximately $1,118–$1,500/month. With GoodRx coupons, the lowest price is approximately $1,118. A full 24-month treatment course can total $26,800–$36,000 at retail. Through AffordMyPrescriptions, qualifying patients receive Oriahnn at no medication cost — our $69.95 monthly fee covers advocacy and program management.
Yes. Oriahnn obtained through the Patient Assistance Program is the same FDA-approved capsules manufactured by the same company that you would receive at any pharmacy.
No. As of April 2026, no generic Oriahnn is available. The combination remains patent- protected with no specific timeline for generic entry. Myfembree is a similar brand-name alternative that may be considered.
The maximum treatment duration is 24 months because long-term estrogen suppression —even with add-back therapy — can affect bone density over time. Your doctor may recommend a baseline bone density scan before starting and periodic monitoring during treatment. After 24 months, your doctor will work with you to determine the best next step for managing your fibroids.
Yes, on a case-by-case exception basis. Patients with insurance or Medicare Part D may also be eligible. Our advocates help navigate the application process to determine your eligibility.
Our Patient Advocates immediately explore every alternative — including the manufacturer’s savings program (commercially insured), GoodRx and SingleCare coupons, Myfembree as an alternative GnRH antagonist combination, insurance prior authorization appeals, and other treatment options such as hormonal IUDs, tranexamic acid, or surgical options that may be covered by your insurance plan.
If you are struggling with the high cost of Oriahnn, our team may be able to help you
access assistance programs designed to make medications more affordable. Check
your eligibility today and take the first step toward reducing your prescription costs.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.